|
|
Volumn 323, Issue 7310, 2001, Pages 415-
|
|
Bayer faces potential fine over cholesterol lowering drug.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CERIVASTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIDINE DERIVATIVE;
ARTICLE;
DRUG INDUSTRY;
DRUG INTERACTION;
DRUG SURVEILLANCE PROGRAM;
ECONOMICS;
GERMANY;
HUMAN;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
DRUG INDUSTRY;
DRUG INTERACTIONS;
GERMANY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PYRIDINES;
|
|
EID: 0035949327
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.323.7310.415a Document Type: Article |
|
Times cited : (10)
|
|
References (0)
|
